Back to RecallTracker
Health Canada Medical devices

Biofire® Blood Culture Identification 2 (BCID2)

Issued February 23, 2024
Issue
Biomérieux has identified an increased risk of false positive candida tropicalis results when the Biofire® BCID2 panel is used with the following BD BACTEC™ blood culture vials. BD BACTEC™ Lytic Anaerobic Medium BD BACTEC™ Peds Plus Medium BD BACTEC™ Plus Aerobic Medium BD BACTEC™ Plus Anaerobic Medium BD BACTEC™ Standard Aerobic Medium BD BACTEC™ Standard Anaerobic Medium Recall start date: February 6, 2024
Hazard description
Performance
Product
Product name
Biofire® Blood Culture Identification 2 (BCID2)
Reference
ID
RA-75069